Table of Contents
OXFORD
UNIVERSITY PRESS
Oxford University Press, Inc., publishes works that further
Oxford Universitys objective of excellence
in research, scholarship, and education.
Oxford New York
Auckland Cape Town Dar es Salaam Hong Kong Karachi
Kuala Lumpur Madrid Melbourne Mexico City Nairobi
New Delhi Shanghai Taipei Toronto
With offices in
Argentina Austria Brazil Chile Czech Republic France Greece
Guatemala Hungary Italy Japan Poland Portugal Singapore
South Korea Switzerland Thailand Turkey Ukraine Vietnam
Copyright 2008 by Oxford University Press, Inc.
Published by Oxford University Press, Inc.
198 Madison Avenue, New York, New York 10016
www.oup.com
Oxford is a registered trademark of Oxford University Press
All rights reserved. No part of this publication may be reproduced,
stored in a retrieval system, or transmitted, in any form or by any means,
electronic, mechanical, photocopying, recording, or otherwise,
without the prior permission of Oxford University Press.
Library of Congress Cataloging-in-Publication Data
Michaels, David, 1954
Doubt is their product : how industrys assault on science
threatens your health / by David Michaels.
p. ; cm.
Includes bibliographical references.
ISBN 978-0-19-530067-3
1. Industrial toxicologyUnited States. 2. Environmental healthUnited States.
3. Science and industryUnited States. 4. LobbyingUnited States.
5. Health risk assessmentUnited States.
[DNLM: 1. Environmental Pollutionadverse effectsUnited States.
2. CarcinogenstoxicityUnited States. 3. IndustrystandardsUnited States.
4. Liability, LegalUnited States. 5. LobbyingUnited States.
6. Public PolicyUnited States. WA 670 M621d 2007] I. Title.
RA1229.M53 2007
615.902dc22 2007010959
1 3 5 7 9 8 6 4 2
Printed in the United States of America
on acid-free paper
For Gail,
Joel, and Lila
Introduction: Sound Science or Sounds Like Science?
Since 1986 every bottle of aspirin sold in the United States has included a label advising parents that consumption by children with viral illnesses greatly increases their risk of developing Reyes syndrome, a serious illness that often involves sudden damage to the brain or liver. Before that mandatory warning was required by the Food and Drug Administration (FDA), the toll from this disease was substantial: In one year1980555 cases were reported, and many others quite likely occurred but went unreported because the syndrome is easily misdiagnosed. One in three diagnosed children died.1
Today, less than a handful of Reyes syndrome cases are reported each yeara public health triumph, surely, but a bittersweet one because an untold number of children died or were disabled while the aspirin manufacturers delayed the FDAs regulation by arguing that the science establishing the aspirin link was incomplete, uncertain, and unclear. The industry raised seventeen specific flaws in the studies and insisted that more reliable ones were needed.2 The medical community knew of the danger, thanks to an alert issued by the Centers for Disease Control (CDC), but parents were kept in the dark. Despite a federal advisory committees concurrence with the CDCs conclusions about the link with aspirin, the industry even issued a public service announcement claiming We do know that no medication has been proven to cause Reyes (emphasis in the original).3 This campaign and the dilatory procedures of the White Houses Office of Management and Budget delayed a public education program for two years and mandatory labels for two more.4 Only litigation by Public Citizens Health Research Group forced the recalcitrant Reagan Administration to act. Thousands of lives have now been savedbut only after hundreds had been lost.
Of course, the aspirin manufacturers did not invent the strategy of preventing or postponing the regulation of hazardous products by questioning the science that reveals the hazards in the first place. I call this strategy manufacturing uncertainty; individual companiesand entire industrieshave been practicing it for decades. Without a doubt, Big Tobacco has manufactured more uncertainty over a longer period and more effectively than any other industry. The title of this book comes from a phrase unwisely committed to paper by a cigarette executive: Doubt is our product since it is the best means of competing with the body of fact that exists in the minds of the general public. It is also the means of establishing a controversy (emphasis added).5
There you have it: the proverbial smoking gun. Big Tobacco, left now without a stitch of credibility or public esteem, has finally abandoned its strategy, but it showed the way. The practices it perfected are alive and well and ubiquitous today. We see this growing trend that disingenuously demands proof over precaution in the realm of public health. In field after field, year after year, conclusions that might support regulation are always disputed. Animal data are deemed not relevant, human data not representative, and exposure data not reliable. Whatever the storyglobal warming, sugar and obesity, secondhand smokescientists in what I call the product defense industry prepare for the release of unfavorable studies even before the studies are published. Public relations experts feed these for-hire scientists contrarian sound bites that play well with reporters, who are mired in the trap of believing there must be two sides to every story. Maybe there are two sidesand maybe one has been bought and paid for.
* * *
As it happens, I have had the opportunity to witness what is going on at close range. In the Clinton administration, I served as Assistant Secretary for Environment, Safety, and Health in the Department of Energy (DOE), the chief safety officer for the nations nuclear weapons facilities. I ran the process through which we issued a strong new rule to prevent chronic beryllium disease, a debilitating and sometimes fatal lung disease prevalent among nuclear weapons workers. The industrys hired guns acknowledged that the current exposure standard for beryllium is not protective for employees. Nevertheless, they claimed, it should not be lowered by any amount until we know with certainty what the exact final number should be.
As a worker, how would you like to be on the receiving end of this logic?
Christie Todd Whitman, the first head of the Environmental Protection Agency under the second President Bush, once said, The absence of certainty is not an excuse to do nothing.6 But it is. Quite simply, the regulatory agencies in Washington, D.C., are intimidated and outgunnedand quiescent. While it is true that industrys uncertainty campaigns exert their influence regardless of the party in power in the nations capital, I believe it is fair to say that, in the administration of President George W. Bush, corporate interests successfully infiltrated the federal government from top to bottom and shaped government science policies to their desires as never before. In October 2002 I was the first author of an editorial in Science that alerted the scientific community to the replacement of national experts in pediatric lead poisoning with lead industry consultants on the pertinent advisory committee.7 Other such attempts to stack advisory panels with individuals chosen for their commitment to a causerather than for their expertiseabound.
Industry has learned that debating the science is much easier and more effective than debating the policy. Take global warming, for example. The vast majority of climate scientists believe there is adequate evidence of global warming to justify immediate intervention to reduce the human contribution. They understand that waiting for absolute certainty is far riskierand potentially far more expensivethan acting responsibly now to control the causes of climate change. Opponents of action, led by the fossil fuels industry, delayed this policy debate by challenging the science with a classic uncertainty campaign. I need cite only a cynical memo that Republican political consultant Frank Luntz delivered to his clients in early 2003. In Winning the Global Warming Debate, Luntz wrote the following: Voters believe that there is no consensus about global warming within the scientific community. Should the public come to believe that the scientific issues are settled, their views about global warming will change accordingly. Therefore, you need to continue to make the lack of scientific certainty a primary issue in the debate....The scientific debate is closing [against us] but not yet closed. There is still a window of opportunity to challenge the science (emphasis in original).8